Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, and Monoclonal and Polyclonal Antibodies Research.
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment
Unleashing the power of anti-HER2 therapies in metastatic colorectal cancer: paving the way for a brighter future
Detection of antibody–drug conjugate-induced interstitial lung disease using circulating cell-free DNA
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases
Immunotherapy for early triple negative breast cancer: research agenda for the next decade
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates
Percutaneous Electrochemotherapy of Malignant Main Portal Veins Thrombosis: A Prospective Case Series
Percutaneous electrochemotherapy of malignant main portal veins thrombosis: a prospective case series.
Percutaneous electrochemotherapy of malignant main portal veins thrombosis: A prospective case series